Self-Reported Symptoms and Concerns in Long-Term Survivors Attending Follow-Up Visits after Hematopoietic Stem Cell Transplantation: A Cross-Sectional Single Center Evaluation in Switzerland
|Monika Kirsch1,3, Jörg Halter1 and Sabina De Geest2,3*|
|1Department of Hematology, University Hospital Basel, Petersgraben 4, 4031 Basel, Switzerland|
|2Center for Health Services and Nursing Research, Katholieke Universiteit Leuven, Kapucijnenvoer 35, 3000 Leuven, Belgium|
|3Institute of Nursing Science, University of Basel, Bernoullistrasse 28, 4056 Basel, Switzerland|
|Corresponding Author :||Sabina De Geest
Institute of Nursing Science, University of Basel
Bernoullistrasse 28, CH-4056 Basel
Tel: +41(0)61 267 30 40
Fax : +41(0)61 267 09 55
E-mail: [email protected]
|Received May 10, 2012; Accepted June 25, 2012; Published June 27, 2012|
|Citation: Kirsch M, Halter J, De Geest S (2012) Self-Reported Symptoms and Concerns in Long-Term Survivors Attending Follow-Up Visits after Hematopoietic Stem Cell Transplantation: A Cross-Sectional Single Center Evaluation in Switzerland. J Nurs Care 1:116. doi:10.4172/2167-1168.1000116|
|Copyright: © 2012 Kirsch M, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.|
Background: Health status self-reports are increasingly recognized as an important source of key follow-up data after hematopoietic stem cell transplantation (HSCT).
Purpose: The purpose of this study was to evaluate the occurrence of self-reported symptoms and concerns in longterm survivors and compare their prevalence’s between allogeneic and autologous transplant recipients with various post-HSCT follow-up lengths.
Interventions/Methods: This cross-sectional survey included a convenience sample of 226 autologous and allogeneic HSCT recipients (54% male; 1 to 26 (median 6) years post-transplant) treated as outpatients by the multidisciplinary team of a Swiss stem cell transplant ambulatory. Symptoms and concerns were measured by a self developed self-report questionnaire.
Results: The median number of self-reported physical symptoms per patient was 5 (IQR 4-10), the most frequent being dry skin (47.8%), tiredness (42%), and dry eyes (42%). The most commonly cited concerns were difficulties managing stressful emotional situations (23.9%), anxiety regarding relapse (22.1%) and memory disturbance (21.2%). There were no notable differences in appraisal of performance and number of symptoms between different time groups.
Conclusion: The high frequency of self-reported symptoms and concerns in long-term survivors indicates a need for continuous monitoring by stem cell transplant follow up clinics, which would allow timely and effective interventions to prevent or alleviate late effects.
Implications for Practice: There seems to be good opportunity for health professionals to support long-term survivors by using self-report as clinical tool in follow-up care. Sharing information about problems and symptoms patients face post-treatment will benefit both professionals and patients.